Printer Friendly

Global Small Molecule, Biopharmaceutical, and Liquid Biopsy Platforms Innovations Report 2019.

M2 PRESSWIRE-November 7, 2019-: Global Small Molecule, Biopharmaceutical, and Liquid Biopsy Platforms Innovations Report 2019



The "Innovations in Small Molecule, Biopharmaceutical, and Liquid Biopsy Platforms" report has been added to's offering.

Some of the technologies profiled include advances related to nerve-on-a-chip technology, use of artificial intelligence for drug discovery, biomarker identification, immunotherapies, mRNA vaccines, cell therapy, drug delivery, and liquid biopsy methods. The TOE also provides a comprehensive listing of key innovators in this space.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Companies Featured

- AxoSim

- Denali Therapeutics

- Yumanity Therapeutics

- Verge Genomics

- QurAlis

- I-Mab Biopharma (Shanghai) Co. Ltd.

- Genexine Inc.

- eTheRNA Immunotherapies NV

- Rubius Therapeutics Inc.

- Rakuten Medical Inc.

- Medigene AG

- Ziopharm Oncology Inc.

- Atara Biotherapeutics Inc.

- Celldex Therapeutics Inc.

- Breath Therapeutics

- Hospital for Sick Children

- Freenome

- Invitae

- TScan Therapeutics

- Myovant Sciences

- Frequency Therapeutics

- PACT Pharma

- Myriad Genetics, Inc.

- Eli Lilly

For more information about this report visit


Laura Wood, Senior Press Manager

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at on the world wide web. Inquiries to

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Presswire
Article Type:Report
Date:Nov 7, 2019
Previous Article:Innovations in Renewable Energy, Fuel Cells, Solar Cells, and Hydrogen Production, 2019 Market Study.
Next Article:Bayer invests USD 50 Million in eGenesis Series B financing round.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters